Published in Pathol Oncol Res on January 01, 1995
Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas. Br J Cancer (1997) 0.79
Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A (1989) 2.11
Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res (1994) 1.90
The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM. Nature (1987) 1.88
Suppression of cellular aggregation by high levels of episialin. Cancer Res (1992) 1.52
A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer (1989) 1.46
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res (1991) 1.41
Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol (1993) 1.39
A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int J Cancer (1989) 1.34
Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. J Immunol (1994) 1.33
Immunological and structural features of the protein core of human polymorphic epithelial mucin. Mol Immunol (1990) 1.27
Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis (1991) 1.23
Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun (1989) 1.05
Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res (1993) 1.03
Molecular changes in carbohydrate antigens associated with cancer. Bioessays (1990) 1.03
High molecular weight epithelial mucins as markers in breast cancer. Eur J Cancer Clin Oncol (1988) 1.01
Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis. Immunol Lett (1993) 0.90
DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets. J Immunol (1990) 0.87
The structure of human intestinal apomucins. Am Rev Respir Dis (1991) 0.84
The breast tumour-associated epithelial mucins and the peanut lectin binding urinary mucins are coded by a single highly polymorphic gene locus 'PUM'. Dis Markers (1988) 0.82
Carbohydrate antigens on cancer-associated mucin-like molecules. Semin Cancer Biol (1991) 0.79
Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer. Int J Cancer (1981) 0.79
Effect of tunicamycin on sialomucin and natural killer susceptibility of rat mammary tumor ascites cells. Cancer Res (1990) 0.79
The polymorphic epithelial mucin as a target for immunotherapy. Ann N Y Acad Sci (1993) 0.78
Expression of monoclonal-antibody-defined antigens in fractions isolated from human breast carcinomas and patients' serum. Cancer Immunol Immunother (1995) 0.77
Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancer. Cancer (1994) 0.77
Immune complexes and prognosis of human breast cancer. Lancet (1978) 0.77
Sequential order of T and B cell epitopes affects immunogenicity but not antibody recognition of the B cell epitope. Pept Res (1995) 0.76
Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens. Cancer Lett (1993) 0.75
Close linkage of PUM and SPTA within chromosome band 1q21. Ann Hum Genet (1988) 0.75
Isolation and electrophoretic analysis of immune complexes from patients with breast cancer. Eur J Cancer Clin Oncol (1981) 0.75
Mucin gel formed by tumorigenic squamous lung carcinoma cells has Le(a)-X oligosaccharides and excludes antibodies from underlying cells. Cancer Res (1992) 0.75
Immune complexes in breast cancer patients as detected by C1q binding. Cancer (1979) 0.75
Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core. Int J Cancer (1993) 0.75
Identification and solution conformation of multiple epitopes recognized by a MUC2 mucin-specific monoclonal antibody. Arch Biochem Biophys (2003) 0.78
Heteroclitic recognition of combinatorial TX1TX2T peptide mixtures by mucin-2 protein specific monoclonal antibody. J Pept Sci (2004) 0.75
Purification of anti-MUC1 antibodies by peptide mimotope affinity chromatography using peptides derived from a polyvalent phage display library. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.75